-
1261
Artificial intelligence links CT images to pathologic features and survival outcomes of renal masses
Published 2025-02-01Get full text
Article -
1262
Role of B7‐H3 in predicting response to neoadjuvant chemotherapy in muscle‐invasive bladder cancer
Published 2024-11-01Get full text
Article -
1263
-
1264
-
1265
-
1266
-
1267
IgG4-Related Kidney Disease: Report of a Case Presenting as a Renal Mass
Published 2017-01-01“…IgG4-related disease (IgG4-RD) is a nosological entity defined as a chronic immune-mediated fibro-inflammatory condition characterized by a tendency to form tumefactive, tissue-destructive lesions or by organ failure. Urologic involvement in IgG4-RD has been described in some short series of patients and in isolated case reports, most often involving the kidneys in so-called IgG4-related kidney disease (IgG4-RKD). …”
Get full text
Article -
1268
-
1269
-
1270
Targeting AURKA with multifunctional nanoparticles in CRPC therapy
Published 2024-12-01Get full text
Article -
1271
Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAP
Published 2025-01-01Get full text
Article -
1272
Targeting Ferroptosis Attenuates Inflammation, Fibrosis, and Mast Cell Activation in Chronic Prostatitis
Published 2022-01-01“…Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common urological disorder. Although ferroptosis is closely associated with inflammation, oxidative stress, and neuropathic pain, its role in CP/CPPS has not yet been elucidated. …”
Get full text
Article -
1273
Therapeutic experience and key techniques of tubeless percutaneous nephrolithotomy
Published 2025-01-01Get full text
Article -
1274
-
1275
Ventral Prostate Fibrosis in the Akita Mouse Is Associated with Macrophage and Fibrocyte Infiltration
Published 2014-01-01Get full text
Article -
1276
Neoantigen immunotherapy: a novel treatment for bladder cancer
Published 2025-01-01Get full text
Article -
1277
ZNF652-Induced circRHOT1 Promotes SMAD5 Expression to Modulate Tumorigenic Properties and Nature Killer Cell-Mediated Toxicity in Bladder Cancer via Targeting miR-3666
Published 2021-01-01“…Bladder cancer (BC) is the 9th most frequent diagnosed tumor and the 2nd most common urology tumor worldwide. Despite the considerable advancement that BC treatment has made recently, the five-year survival rate of BC remains unsatisfactory. …”
Get full text
Article -
1278
-
1279
-
1280